NLM Logo

Antineoplastic Agents MeSH Descriptor Data 2022


MeSH Heading
Antineoplastic Agents
Tree Number(s)
D27.505.954.248
Unique ID
D000970
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000970
Annotation
/admin: various administration procedures are available, as CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHEMOEMBOLIZATION, THERAPEUTIC and INFUSIONS, INTRA-ARTERIAL; for combined anticancer agents, ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; Manual 24.4.2.1+
Scope Note
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Entry Version
ANTINEOPL AGENTS
Entry Term(s)
Anticancer Agent
Anticancer Agents
Antineoplastic
Antineoplastic Agent
Antineoplastic Drug
Antineoplastic Drugs
Antineoplastics
Antitumor Agent
Antitumor Agents
Antitumor Drug
Antitumor Drugs
Cancer Chemotherapy Agent
Cancer Chemotherapy Agents
Cancer Chemotherapy Drug
Cancer Chemotherapy Drugs
Chemotherapeutic Anticancer Agents
Chemotherapeutic Anticancer Drug
Registry Number
0
NLM Classification #
QV 269
See Also
Anticarcinogenic Agents
Chemoembolization, Therapeutic
Chemotherapy, Cancer, Regional Perfusion
Cytotoxins
Infusions, Intra-Arterial
Tumor Lysis Syndrome
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2020/05/27
Antineoplastic Agents Preferred
page delivered in 0.174s